Log In
BCIQ
Print this Print this
 

Familion CPVT test

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionPharmacogenetic test to detect mutations associated with catecholaminergic polymorphic ventricular tachycardia (CPVT)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsDetect mutations associated with catecholaminergic polymorphic ventricular tachycardia (CPVT)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today